Clinical Trials Browser

Phase 1/2 × rasburicase × Clear all

NCT00360438 2012-08-01

Pharmacokinetic Evaluation of Rasburicase in Patients With Leukemia and/or Lymphoma at High Risk of TLS

Phase 1/2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Tumor Lysis Syndrome